Unitekhprom BSU

Unitekhprom BSU is a specialized scientific and production enterprise affiliated with the Belarusian State University, focusing on the translation of academic research into commercial pharmaceutical products. The company is primarily recognized for its innovative work in oncology, specifically the development of hydrogel-based drug delivery systems that allow for the local application of chemotherapy. Their portfolio includes proprietary drugs like Temodex and Cisplatcel, which are used to treat brain tumors by delivering active agents directly to the surgical cavity, thereby reducing systemic toxicity. Beyond oncology, the enterprise produces specialized nutrition, diagnostic reagents, and veterinary medicines. Unitekhprom BSU operates GMP-compliant facilities and serves as a significant hub for biotechnology and pharmaceutical manufacturing within the CIS region.